Published in AIDS Weekly, December 23rd, 1996
"Our study does not allow firm conclusions to be drawn because it was not designed to evaluate the efficacy of lamivudine against HBV infection, but our data indicate that lamivudine may have a role in HIV infected patients," research Yves Benhamou and colleagues from Paris' Hospitalier Pitie-Salpetriere wrote ("Effects of Lamivudine on Replication of Hepatitis B Virus in HIV Infected Men," Annals of Internal Medicine, November 1,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.